Cover Image

Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study

Objective: Metformin as a common antidiabetic drug, has recently found to exert its anti-cancer and immunomodulatory effect in numerous preclinical studies. This study aims to clarify the prognostic impact of metformin use in solid cancer patients receiving immune checkpoint inhibitors (ICIs).Method...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiaxin Wang (Author), Jie Lin (Author), Huaijuan Guo (Author), Wenjuan Wu (Author), Jingjing Yang (Author), Jingxian Mao (Author), Wenbin Fan (Author), Hong Qiao (Author), Ying Wang (Author), Xuebing Yan (Author), Hong Guo (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
by: Danielle Gilbert, et al.
Published: (2023)

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study
by: Danielle Delombaerde, et al.
Published: (2023)

Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma
by: Jie Lin, et al.
Published: (2024)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
by: Yang Wen, et al.
Published: (2021)

Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
by: Shanshan Hu, et al.
Published: (2022)

Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
by: Yi Wang, et al.
Published: (2024)

Association of possible sarcopenia with all-cause mortality in patients with solid cancer: A nationwide multicenter cohort study
by: Liangyu Yin, et al.
Published: (2024)

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
by: Liyan Zhang, et al.
Published: (2021)

The Role and Mechanism of Metformin in Inflammatory Diseases
by: Lin H, et al.
Published: (2023)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
by: Yan Wang, et al.
Published: (2023)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)

Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
by: Yanmeizhi Wu, et al.
Published: (2022)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024)

The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers
by: Guojing Liu, et al.
Published: (2016)

Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapy
by: Lilong Zhang, et al.
Published: (2022)

Fundamentals and Applications of Focused Ultrasound-Assisted Cancer Immune Checkpoint Inhibition for Solid Tumors
by: Sepideh Jahangiri, et al.
Published: (2024)

Advances in the development of amorphous solid dispersions: The role of polymeric carriers
by: Jie Zhang, et al.
Published: (2023)

Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung Cancer
by: Wang S, et al.
Published: (2024)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022)

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
by: Qiuyu Wu, et al.
Published: (2023)

Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta‐analysis
by: Yukinori Takenaka, et al.
Published: (2021)

Experience of using a smartphone WeChat applet for dental anxiety assessment and preoperative evaluation: A nationwide multicenter study
by: Xilu Huang, et al.
Published: (2022)

Mobile App for Gynecologic Cancer Support for Patients With Gynecologic Cancer Receiving Chemotherapy in China: Multicenter Randomized Controlled Trial
by: Huicong Lin, et al.
Published: (2023)

Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone
by: Jingwen Gan, et al.
Published: (2023)

Metformin Inhibits the Expression of Biomarkers of Fibrosis of EPCs In Vitro
by: Fei Han, et al.
Published: (2019)

Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy
by: Matthew D Biniakewitz, et al.
Published: (2021)

Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors
by: Danielle Delombaerde, et al.
Published: (2024)

Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
by: Xinyu Yan, et al.
Published: (2018)

Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot
by: Wang Liao, et al.
Published: (2022)

What's new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
by: Patricia C. Tsang, et al.
Published: (2022)

Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China
by: Xinquan Lan, et al.
Published: (2023)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
by: Yuchun Niu, et al.
Published: (2020)

Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation
by: Dennis Niebel, et al.
Published: (2022)

Safety and efficacy of compound methyl salicylate liniment for topical pain: A multicenter real-world study in China
by: Jie Guo, et al.
Published: (2022)

The prevalence of non-sentinel lymph node metastasis among breast cancer patients with sentinel lymph node involvement and its impact on clinical decision-making: a single-centred retrospective study
by: Jingxian Ding, et al.
Published: (2024)

A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
by: Renguo Guan, et al.
Published: (2022)

The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia
by: Osamah M. Alfayez, et al.
Published: (2022)

Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China
by: Xiujuan Zhang, et al.
Published: (2021)

Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor
by: Tao Tan, et al.
Published: (2020)

Local delivery of checkpoints antibodies
by: Chao Wang, et al.
Published: (2017)